From the source
C-BRAIN, a consortium of 18 institutions working with NVIDIA, is building AI tools to speed up Alzheimer's research by making previously inaccessible data usable for scientists.
- The group says the field's bottleneck is not effort but too much data, too few experts to synthesize it and a pace of discovery that cannot keep up with the disease.
- C-BRAIN calls the unpublished findings, negative results and governed proprietary data held by member institutions "dark data," and uses a hybrid centralized and federated approach so models learn from data at each institution without it leaving its walls.
- The consortium runs 64 NVIDIA data center GPUs on premises alongside cloud-based nodes on
Microsoft Azure, with additional NVIDIA GPU capacity, including NVIDIA Blackwell systems, planned as it scales.
- It is incorporating the NVIDIA BioNeMo open developer platform and the MONAI framework into its research pipelines.
- Researchers have built two open source tools: OpenScientist, an agentic AI co-scientist that generates hypotheses and produces auditable insights, and InsightEngine, which tests hypotheses against the scientific literature and checks claims against evidence to catch hallucinations.
